APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kallikrein Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Kallikrein Inhibitors Industry Growth and Trends Forecast to 2032

28 December 202571 pages

Choose your research edition.

Industry ResearchKallikrein Inhibitors Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Kallikrein Inhibitors Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Kallikrein Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kallikrein Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Kallikrein Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Kallikrein Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kallikrein Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kallikrein Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kallikrein Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kallikrein Inhibitors include BioCryst Pharmaceuticals and Takeda Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kallikrein Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kallikrein Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kallikrein Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kallikrein Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kallikrein Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kallikrein Inhibitors Market by Company

BioCryst Pharmaceuticals

Takeda Pharmaceuticals

Kallikrein Inhibitors Segment by Type

Capsules

Injections

Kallikrein Inhibitors Segment by Application

Hospital and Clinic

Pharmacy

Other

Kallikrein Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kallikrein Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kallikrein Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kallikrein Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kallikrein Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kallikrein Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Injections Table 3. Global Kallikrein Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 5. Global Kallikrein Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global Kallikrein Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global Kallikrein Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 9. Global Kallikrein Inhibitors Sales by Type (2027-2032) & (K Units) Table 10. Global Kallikrein Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global Kallikrein Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global Kallikrein Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global Kallikrein Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 14. North America Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 15. North America Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. Europe Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Latin America Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Kallikrein Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Kallikrein Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. Kallikrein Inhibitors Industry Trends Table 25. Kallikrein Inhibitors Industry Drivers Table 26. Kallikrein Inhibitors Industry Opportunities and Challenges Table 27. Kallikrein Inhibitors Industry Restraints Table 28. Global Kallikrein Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Kallikrein Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global Kallikrein Inhibitors Sales by Company (2021-2026) & (K Units) Table 31. Global Kallikrein Inhibitors Sales Share by Company (2021-2026) Table 32. Global Kallikrein Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Kallikrein Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Kallikrein Inhibitors Major Company Production Sites and Headquarters Table 35. Global Kallikrein Inhibitors Company, Product Type & Application Table 36. Global Kallikrein Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Kallikrein Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Kallikrein Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Kallikrein Inhibitors Sales by Region (2021-2026) & (K Units) Table 41. Global Kallikrein Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global Kallikrein Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global Kallikrein Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global Kallikrein Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Kallikrein Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global Kallikrein Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global Kallikrein Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global Kallikrein Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global Kallikrein Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Kallikrein Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global Kallikrein Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global Kallikrein Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global Kallikrein Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global Kallikrein Inhibitors Sales by Application (2027-2032) & (K Units) Table 57. Global Kallikrein Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global Kallikrein Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global Kallikrein Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global Kallikrein Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 61. North America Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 62. North America Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. Europe Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Latin America Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Kallikrein Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Kallikrein Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. BioCryst Pharmaceuticals Company Information Table 72. BioCryst Pharmaceuticals Business Overview Table 73. BioCryst Pharmaceuticals Kallikrein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. BioCryst Pharmaceuticals Kallikrein Inhibitors Product Portfolio Table 75. BioCryst Pharmaceuticals Recent Development Table 76. Takeda Pharmaceuticals Company Information Table 77. Takeda Pharmaceuticals Business Overview Table 78. Takeda Pharmaceuticals Kallikrein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Pharmaceuticals Kallikrein Inhibitors Product Portfolio Table 80. Takeda Pharmaceuticals Recent Development Table 81. North America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Kallikrein Inhibitors Sales by Country (2021-2026) & (K Units) Table 83. North America Kallikrein Inhibitors Sales Market Share by Country (2021-2026) Table 84. North America Kallikrein Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Kallikrein Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 86. North America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Kallikrein Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Kallikrein Inhibitors Market Share by Country (2021-2026) Table 89. North America Kallikrein Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Kallikrein Inhibitors Market Share Forecast by Country (2027-2032) Table 91. Europe Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Kallikrein Inhibitors Sales by Country (2021-2026) & (K Units) Table 93. Europe Kallikrein Inhibitors Sales Market Share by Country (2021-2026) Table 94. Europe Kallikrein Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Kallikrein Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Kallikrein Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Kallikrein Inhibitors Market Share by Country (2021-2026) Table 99. Europe Kallikrein Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Kallikrein Inhibitors Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Kallikrein Inhibitors Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Kallikrein Inhibitors Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Kallikrein Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Kallikrein Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Kallikrein Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Kallikrein Inhibitors Market Share by Country (2021-2026) Table 109. Asia-Pacific Kallikrein Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Kallikrein Inhibitors Market Share Forecast by Country (2027-2032) Table 111. Latin America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Kallikrein Inhibitors Sales by Country (2021-2026) & (K Units) Table 113. Latin America Kallikrein Inhibitors Sales Market Share by Country (2021-2026) Table 114. Latin America Kallikrein Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Kallikrein Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Kallikrein Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Kallikrein Inhibitors Market Share by Country (2021-2026) Table 119. Latin America Kallikrein Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Kallikrein Inhibitors Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Kallikrein Inhibitors Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Kallikrein Inhibitors Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Kallikrein Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Kallikrein Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Kallikrein Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Kallikrein Inhibitors Market Share by Country (2021-2026) Table 129. Middle East and Africa Kallikrein Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Kallikrein Inhibitors Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Kallikrein Inhibitors Distributors List Table 134. Kallikrein Inhibitors Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Kallikrein Inhibitors Image Figure 2. Global Kallikrein Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kallikrein Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Kallikrein Inhibitors Sales (2021-2032) & (K Units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injections Image Figure 8. Global Injections Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Kallikrein Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Kallikrein Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America Kallikrein Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America Kallikrein Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe Kallikrein Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe Kallikrein Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Kallikrein Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Kallikrein Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America Kallikrein Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Kallikrein Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Kallikrein Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Kallikrein Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Kallikrein Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Kallikrein Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Kallikrein Inhibitors Market Share by Application 2025 VS 2032 Figure 31. North America Kallikrein Inhibitors Sales Market Share in Volume by Application in 2025 Figure 32. North America Kallikrein Inhibitors Sales Market Share in Value by Application in 2025 Figure 33. Europe Kallikrein Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. Europe Kallikrein Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Kallikrein Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Kallikrein Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Latin America Kallikrein Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Kallikrein Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Kallikrein Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Kallikrein Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. North America Kallikrein Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Kallikrein Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Kallikrein Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Kallikrein Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Kallikrein Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Kallikrein Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Kallikrein Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Kallikrein Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Kallikrein Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Kallikrein Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Kallikrein Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Kallikrein Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Kallikrein Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Kallikrein Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Kallikrein Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Kallikrein Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Kallikrein Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Kallikrein Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Kallikrein Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Kallikrein Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Kallikrein Inhibitors Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Kallikrein Inhibitors Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Injections
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • BioCryst Pharmaceuticals
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kallikrein Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kallikrein Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kallikrein Inhibitors Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Injections
  8. 1.4 Global Kallikrein Inhibitors Market Size by Type
  9. 1.4.1 Global Kallikrein Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Kallikrein Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Kallikrein Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Kallikrein Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Kallikrein Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Kallikrein Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Kallikrein Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Kallikrein Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kallikrein Inhibitors Industry Trends
  2. 2.2 Kallikrein Inhibitors Industry Drivers
  3. 2.3 Kallikrein Inhibitors Industry Opportunities and Challenges
  4. 2.4 Kallikrein Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kallikrein Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Kallikrein Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Kallikrein Inhibitors Price (2021-2026)
  4. 3.4 Global Kallikrein Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kallikrein Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Kallikrein Inhibitors Company, Product Type & Application
  7. 3.7 Global Kallikrein Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kallikrein Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kallikrein Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kallikrein Inhibitors Tier 1, Tier 2, and Tier 3
4 Kallikrein Inhibitors Regional Status and Outlook
  1. 4.1 Global Kallikrein Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kallikrein Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Kallikrein Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kallikrein Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kallikrein Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kallikrein Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Kallikrein Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kallikrein Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kallikrein Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kallikrein Inhibitors by Application
  1. 5.1 Kallikrein Inhibitors Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Kallikrein Inhibitors Market Size by Application
  6. 5.2.1 Global Kallikrein Inhibitors Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Kallikrein Inhibitors Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Kallikrein Inhibitors Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Kallikrein Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Kallikrein Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Kallikrein Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Kallikrein Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Kallikrein Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioCryst Pharmaceuticals
  2. 6.1.1 BioCryst Pharmaceuticals Company Information
  3. 6.1.2 BioCryst Pharmaceuticals Business Overview
  4. 6.1.3 BioCryst Pharmaceuticals Kallikrein Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioCryst Pharmaceuticals Kallikrein Inhibitors Product Portfolio
  6. 6.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 6.2 Takeda Pharmaceuticals
  8. 6.2.1 Takeda Pharmaceuticals Company Information
  9. 6.2.2 Takeda Pharmaceuticals Business Overview
  10. 6.2.3 Takeda Pharmaceuticals Kallikrein Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceuticals Kallikrein Inhibitors Product Portfolio
  12. 6.2.5 Takeda Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Kallikrein Inhibitors Sales by Country
  2. 7.1.1 North America Kallikrein Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kallikrein Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Kallikrein Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kallikrein Inhibitors Market Size by Country
  6. 7.2.1 North America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kallikrein Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Kallikrein Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kallikrein Inhibitors Sales by Country
  2. 8.1.1 Europe Kallikrein Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kallikrein Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Kallikrein Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kallikrein Inhibitors Market Size by Country
  6. 8.2.1 Europe Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kallikrein Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kallikrein Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kallikrein Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Kallikrein Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kallikrein Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kallikrein Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kallikrein Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kallikrein Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kallikrein Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kallikrein Inhibitors Sales by Country
  2. 10.1.1 South America Kallikrein Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kallikrein Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Kallikrein Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kallikrein Inhibitors Market Size by Country
  6. 10.2.1 South America Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kallikrein Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Kallikrein Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kallikrein Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Kallikrein Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kallikrein Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kallikrein Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kallikrein Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Kallikrein Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kallikrein Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kallikrein Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kallikrein Inhibitors Value Chain Analysis
  2. 12.1.1 Kallikrein Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kallikrein Inhibitors Production Mode & Process
  7. 12.2 Kallikrein Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kallikrein Inhibitors Distributors
  10. 12.2.3 Kallikrein Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst